Abstract
Recent approaches to determine optimal antimicrobial treatment for acute pelvic inflammatory disease are reviewed. From this review, it is suggested that in future studies a randomized study design, with controls for known factors which influence prognosis, and a uniform objective scoring system for monitoring clinical response be used and long-term evaluation of tubal function be performed. Such studies are urgently needed if optimal therapy for pelvic inflammatory disease is to be defined.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
